- Home
- SOWG vs VTGN Comparison
SOWG vs VTGN Comparison
Compare SOWG & VTGN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | SOWG | VTGN |
|---|---|---|
| Founded | 2010 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Packaged Foods | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 25.4M | 24.1M |
| IPO Year | 2011 | 2014 |
Fundamental Metrics
Financial Performance| Metric | SOWG | VTGN |
|---|---|---|
| Price | $3.97 | $0.69 |
| Analyst Decision | | Hold |
| Analyst Count | 0 | 3 |
| Target Price | N/A | ★ $0.90 |
| AVG Volume (30 Days) | 148.3K | ★ 849.2K |
| Earning Date | 05-15-2026 | 06-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ N/A | N/A |
| Revenue This Year | N/A | $124.49 |
| Revenue Next Year | N/A | $353.99 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $0.10 | $0.43 |
| 52 Week High | $4.45 | $5.14 |
Technical Indicators
Market Signals| Indicator | SOWG | VTGN |
|---|---|---|
| Relative Strength Index (RSI) | 86.28 | 60.68 |
| Support Level | $0.48 | $0.54 |
| Resistance Level | N/A | $0.77 |
| Average True Range (ATR) | 0.40 | 0.06 |
| MACD | 0.20 | 0.01 |
| Stochastic Oscillator | 81.23 | 71.52 |
Price Performance
Historical ComparisonAbout SOWG Sow Good Inc.
Sow Good Inc is engaged in manufacturing and marketing freeze-dried fruits, vegetables, snacks, smoothies, and soups. The company also sells gluten-free products under the Sow Good brand. The company is developing a freeze-dried candy market and snack manufacturing to provide consumers with flavorful freeze-dried treats. The company operates in one reportable segment, reflecting its capital-light business model under which it earns proceeds from the sale of freeze-dried candy products.
About VTGN VistaGen Therapeutics Inc.
Vistagen Therapeutics Inc is a biotechnology firm. The company is neuroscience-focused biopharmaceutical company dedicated to pursuing a pioneering approach to the development and commercialization of groundbreaking therapies for psychiatric and neurological disorders based on deep understanding of nose-to-brain neurocircuitry.